Investor Calendar
October 13, 2017
Investor Calendar
-
Annual general meeting
- Q2 report, 2018/19
Upcoming events
- Meet us at a conference devoted to the problem of primary and acquired therapy resistance associated with disease progression and poor clinical outcome in cancer patients.